Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pet-ct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04005963
What this trial is testing

The Value of PET Quantitative Analysis of Coronary Physiology in Coronary Microvascular Disease

Who this might be right for
PET / CTCoronary Microvascular Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150
Not applicableLooking for participantsNCT05688592
What this trial is testing

Usefulness of PET-CT for Invasive Fungal Infection

Who this might be right for
Invasive Fungal Infections
Puerta de Hierro University Hospital 224
Testing effectiveness (Phase 2)Active Not RecruitingNCT04692103
What this trial is testing

Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Who this might be right for
Estrogen Receptor PositivePrimary or Recurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 2
Not applicableLooking for participantsNCT06359795
What this trial is testing

Exploring the Value of 18F-AlF-FAPI PET/CT in Assessing the Activity of Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Peking University Third Hospital 50
Not applicableStudy completedNCT03081767
What this trial is testing

Standard PET/CT vs. Digital PET/CT

Who this might be right for
Cancer
Stanford University 199
Very early researchWithdrawnNCT03295695
What this trial is testing

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Who this might be right for
Breast CancerBreast Cancer, FemaleBreast Cancer, Male+1 more
H. Lee Moffitt Cancer Center and Research Institute
Early research (Phase 1)Study completedNCT00961831
What this trial is testing

Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

Who this might be right for
Neoplasm
Bayer 20
Large-scale testing (Phase 3)Study completedNCT02883153
What this trial is testing

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT03416153
What this trial is testing

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Who this might be right for
Oropharynx Cancer
University of Michigan Rogel Cancer Center 91
Testing effectiveness (Phase 2)Ended earlyNCT04928820
What this trial is testing

68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+3 more
Jonsson Comprehensive Cancer Center 22
Not applicableLooking for participantsNCT04882488
What this trial is testing

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis

Who this might be right for
Aortic Valve StenosisCoronary Artery Disease
Heart and Diabetes Center North-Rhine Westfalia 20
Not applicableStudy completedNCT01751737
What this trial is testing

Choline PET/CT and MRI for Targeted Prostate Biopsy

Who this might be right for
Prostate Cancer
University of Michigan 63
Not applicableLooking for participantsNCT07046702
What this trial is testing

68Ga-MY6349 PET/CT in Solid Tumors

Who this might be right for
Solid TumorTrop2PET/CT
The First Affiliated Hospital of Xiamen University 300
Not applicableNot Yet RecruitingNCT07114172
What this trial is testing

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Who this might be right for
Melanoma (Skin Cancer)Health VolunteersPET / CT
Xijing Hospital 15
Large-scale testing (Phase 3)UnknownNCT05749302
What this trial is testing

Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins

Who this might be right for
Malignancy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 500
Post-approval studies (Phase 4)Study completedNCT02187172
What this trial is testing

Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)

Who this might be right for
PsoriasisCardiovascular Disease
University of Pennsylvania 43
Not applicableEnrolling By InvitationNCT06610695
What this trial is testing

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals

Who this might be right for
CholestasisGenetic Liver Disorder
University of Aarhus 22
Post-approval studies (Phase 4)Ended earlyNCT01321996
What this trial is testing

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 29
Not applicableUnknownNCT06207747
What this trial is testing

Quantitative Analysis of PET/CT Images of Immune Related Side Effects in Metastatic Melanoma Patients

Who this might be right for
MelanomaPET CT
Institute of Oncology Ljubljana 70
Not applicableLooking for participantsNCT07174089
What this trial is testing

New AI-based Technologies in Nuclear Medicine

Who this might be right for
Patients Undergoing PET/CT Investigation or Nuclear Medicine Therapy
Azienda USL Reggio Emilia - IRCCS 1,500
Next Page